JP2022524077A5 - - Google Patents
Info
- Publication number
- JP2022524077A5 JP2022524077A5 JP2021552999A JP2021552999A JP2022524077A5 JP 2022524077 A5 JP2022524077 A5 JP 2022524077A5 JP 2021552999 A JP2021552999 A JP 2021552999A JP 2021552999 A JP2021552999 A JP 2021552999A JP 2022524077 A5 JP2022524077 A5 JP 2022524077A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815553P | 2019-03-08 | 2019-03-08 | |
| US62/815,553 | 2019-03-08 | ||
| PCT/US2020/021479 WO2020185593A1 (en) | 2019-03-08 | 2020-03-06 | Azetidinyl 0-glyc0pr0tein-2-acetamid0-2-deoxy-3-d-gluc0pyran0sidase inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022524077A JP2022524077A (ja) | 2022-04-27 |
| JP2022524077A5 true JP2022524077A5 (https=) | 2023-03-14 |
| JPWO2020185593A5 JPWO2020185593A5 (https=) | 2023-03-14 |
| JP7663503B2 JP7663503B2 (ja) | 2025-04-16 |
Family
ID=69960768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552999A Active JP7663503B2 (ja) | 2019-03-08 | 2020-03-06 | アゼチジニルｏ－糖タンパク質－２－アセトアミド－２－デオキシ－３－ｄ－グルコピラノシダーゼ阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12421224B2 (https=) |
| EP (1) | EP3935055A1 (https=) |
| JP (1) | JP7663503B2 (https=) |
| MA (1) | MA55203A (https=) |
| WO (1) | WO2020185593A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121405694A (zh) * | 2024-07-26 | 2026-01-27 | 浙江同源康医药股份有限公司 | Oga抑制剂及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| EP2780013A4 (en) | 2011-11-18 | 2015-07-01 | Constellation Pharmaceuticals Inc | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF |
| EP2780014A4 (en) | 2011-11-18 | 2015-07-01 | Constellation Pharmaceuticals Inc | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF |
| WO2013078320A1 (en) | 2011-11-21 | 2013-05-30 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
| NZ628762A (en) | 2012-02-10 | 2016-07-29 | Constellation Pharmaceuticals Inc | Modulators of methyl modifying enzymes, compositions and uses thereof |
| SI2953941T1 (sl) | 2013-02-11 | 2017-08-31 | Constellation Pharmaceuticals, Inc. | Modulatorji metil-modificirajočih encimov, sestavki in uporabe le-teh |
| RS58768B1 (sr) * | 2013-03-14 | 2019-06-28 | Merck Patent Gmbh | Inhibitori glikozidaze |
| WO2014151142A1 (en) | 2013-03-15 | 2014-09-25 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| EP3033334A1 (en) | 2013-08-15 | 2016-06-22 | Constellation Pharmaceuticals, Inc. | Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof |
| CA3045957A1 (en) | 2016-12-16 | 2018-06-21 | Janssen Pharmaceutica Nv | Monocyclic oga inhibitor compounds |
| WO2018154133A1 (en) | 2017-02-27 | 2018-08-30 | Janssen Pharmaceutica Nv | [1,2,4]-triazolo [1,5-a]-pyrimidinyl derivatives substituted with piperidine, morpholine or piperazine as oga inhibitors |
-
2020
- 2020-03-06 JP JP2021552999A patent/JP7663503B2/ja active Active
- 2020-03-06 MA MA055203A patent/MA55203A/fr unknown
- 2020-03-06 WO PCT/US2020/021479 patent/WO2020185593A1/en not_active Ceased
- 2020-03-06 US US17/435,125 patent/US12421224B2/en active Active
- 2020-03-06 EP EP20714094.8A patent/EP3935055A1/en active Pending